According to CNET,An independent committee advising the U.S. Food and Drug Administration (FDA) voted on Tuesday to recommend Pfizer’s COVID-19 vaccine for children aged 5 to 11.In the United States, children 12 years and older are already eligible for the vaccine. Pfizer’s vaccine dose for young children is one-third that of people 12 years and older, and it is a two-dose series of vaccines given three weeks apart. According to the “New York Times” report, once authorized, it may affect more than 28 million children.
The panel’s vote will need to be formally accepted and authorized by the FDA itself. Once authorized, an independent committee that provides guidance to the Centers for Disease Control and Prevention (CDC) will meet to determine how children should be vaccinated against COVID-19 or whether they should make special recommendations. This means that children between 5 and 11 years of age may be vaccinated as early as next week.
Some members of the FDA team seem to depend on the discussions and guidance that the CDC team will issue, including how parents should be instructed to seek vaccines for their young children, or whether some people should get them eligible earlier than others Vaccinate children with conditions. In the end, committee members voted that the benefits of allowing young children to be vaccinated against COVID-19 outweigh the risks.
Although children are less likely than adults to become seriously ill or die from COVID-19, they account for a significant proportion of reported COVID-19 cases. Long COVID, a lingering symptom that affects many people who have recovered from COVID-19, has also been reported in children.
There are also ethnic differences in the extent to which children become ill due to COVID-19. According to the report, black, Native American, or Hispanic children are more than three times more likely to be hospitalized due to COVID-19 than white children. Approximately one third of children aged 5 to 11 who are hospitalized due to COVID-19 need to be admitted to the ICU.